These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 32890701)
1. Identification of a prognostic signature of epithelial ovarian cancer based on tumor immune microenvironment exploration. Liu J; Meng H; Nie S; Sun Y; Jiang P; Li S; Yang J; Sun R; Cheng W Genomics; 2020 Nov; 112(6):4827-4841. PubMed ID: 32890701 [TBL] [Abstract][Full Text] [Related]
2. A prognostic model based on immune-related long noncoding RNAs for patients with epithelial ovarian cancer. Peng Y; Wang H; Huang Q; Wu J; Zhang M J Ovarian Res; 2022 Jan; 15(1):8. PubMed ID: 35031063 [TBL] [Abstract][Full Text] [Related]
3. A novel immune-related prognostic signature in epithelial ovarian carcinoma. Su T; Zhang P; Zhao F; Zhang S Aging (Albany NY); 2021 Apr; 13(7):10289-10311. PubMed ID: 33819196 [TBL] [Abstract][Full Text] [Related]
4. Multi-omics analysis of tumor mutational burden combined with prognostic assessment in epithelial ovarian cancer based on TCGA database. Liu J; Xu W; Li S; Sun R; Cheng W Int J Med Sci; 2020; 17(18):3200-3213. PubMed ID: 33173439 [No Abstract] [Full Text] [Related]
5. Acetylation model predicts prognosis of patients and affects immune microenvironment infiltration in epithelial ovarian carcinoma. Wang X; Li X; Wei L; Yu Y; Hazaisihan Y; Tao L; Jia W J Ovarian Res; 2024 Jul; 17(1):150. PubMed ID: 39030559 [TBL] [Abstract][Full Text] [Related]
6. A new nomogram model for prognosis of hepatocellular carcinoma based on novel gene signature that regulates cross-talk between immune and tumor cells. Wang Y; Yang Y; Zhao Z; Sun H; Luo D; Huttad L; Zhang B; Han B BMC Cancer; 2022 Apr; 22(1):379. PubMed ID: 35397536 [TBL] [Abstract][Full Text] [Related]
7. An immune-related prognostic signature for thyroid carcinoma to predict survival and response to immune checkpoint inhibitors. Wu P; Sun W; Zhang H Cancer Immunol Immunother; 2022 Mar; 71(3):747-759. PubMed ID: 34398303 [TBL] [Abstract][Full Text] [Related]
8. Identification of immune-related gene signature predicting survival in the tumor microenvironment of lung adenocarcinoma. Zhao M; Li M; Chen Z; Bian Y; Zheng Y; Hu Z; Liang J; Huang Y; Yin J; Zhan C; Feng M; Wang Q Immunogenetics; 2020 Dec; 72(9-10):455-465. PubMed ID: 33188484 [TBL] [Abstract][Full Text] [Related]
9. Development of a macrophages-related 4-gene signature and nomogram for the overall survival prediction of hepatocellular carcinoma based on WGCNA and LASSO algorithm. Yang Z; Zi Q; Xu K; Wang C; Chi Q Int Immunopharmacol; 2021 Jan; 90():107238. PubMed ID: 33316739 [TBL] [Abstract][Full Text] [Related]
10. Development of a prognostic signature for esophageal cancer based on nine immune related genes. Zhang Z; Chen C; Fang Y; Li S; Wang X; Sun L; Zhou G; Ye J BMC Cancer; 2021 Feb; 21(1):113. PubMed ID: 33541291 [TBL] [Abstract][Full Text] [Related]
11. Development of an immune gene prognostic classifier for survival prediction and respond to immunocheckpoint inhibitor therapy/chemotherapy in endometrial cancer. Liu J; Chen X; Jiang Y; Cheng W Int Immunopharmacol; 2020 Sep; 86():106735. PubMed ID: 32619957 [TBL] [Abstract][Full Text] [Related]
12. A methylation-driven genes prognostic signature and the immune microenvironment in epithelial ovarian cancer. Tan M; Wang S; Li F; Xu H; Gao J; Zhu L Carcinogenesis; 2022 Aug; 43(7):635-646. PubMed ID: 35639961 [TBL] [Abstract][Full Text] [Related]
13. ATP2C2 Has Potential to Define Tumor Microenvironment in Breast Cancer. Liu J; Wei Y; Wu Y; Li J; Sun J; Ren G; Li H Front Immunol; 2021; 12():657950. PubMed ID: 33936088 [TBL] [Abstract][Full Text] [Related]
14. A robust signature associated with patient prognosis and tumor immune microenvironment based on immune-related genes in lung squamous cell carcinoma. Zhou H; Zhang H; Shi M; Wang J; Huang Z; Shi J Int Immunopharmacol; 2020 Nov; 88():106856. PubMed ID: 32777677 [TBL] [Abstract][Full Text] [Related]
15. Identification of a prognostic and therapeutic immune signature associated with hepatocellular carcinoma. Peng Y; Liu C; Li M; Li W; Zhang M; Jiang X; Chang Y; Liu L; Wang F; Zhao Q Cancer Cell Int; 2021 Feb; 21(1):98. PubMed ID: 33568167 [TBL] [Abstract][Full Text] [Related]
16. A prognostic signature based on immune-related genes for cervical squamous cell carcinoma and endocervical adenocarcinoma. Liu J; Wu Z; Wang Y; Nie S; Sun R; Yang J; Cheng W Int Immunopharmacol; 2020 Nov; 88():106884. PubMed ID: 32795900 [TBL] [Abstract][Full Text] [Related]
17. Development and validation of an immune gene-set based prognostic signature for soft tissue sarcoma. Shen R; Liu B; Li X; Yu T; Xu K; Ma J BMC Cancer; 2021 Feb; 21(1):144. PubMed ID: 33557781 [TBL] [Abstract][Full Text] [Related]
18. Identification of a prognostic immune signature for cervical cancer to predict survival and response to immune checkpoint inhibitors. Yang S; Wu Y; Deng Y; Zhou L; Yang P; Zheng Y; Zhang D; Zhai Z; Li N; Hao Q; Song D; Kang H; Dai Z Oncoimmunology; 2019; 8(12):e1659094. PubMed ID: 31741756 [TBL] [Abstract][Full Text] [Related]
19. Immune-Stromal Score Signature: Novel Prognostic Tool of the Tumor Microenvironment in Lung Adenocarcinoma. Qi X; Qi C; Qin B; Kang X; Hu Y; Han W Front Oncol; 2020; 10():541330. PubMed ID: 33072571 [No Abstract] [Full Text] [Related]
20. Development of a prognostic signature based on immune-related genes and the correlation with immune microenvironment in breast cancer. Dong M; Cui X; Wang G; Zhang Q; Li X Aging (Albany NY); 2022 Jul; 14(13):5427-5448. PubMed ID: 35793235 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]